Keywords: mochida, ifn-beta, approved, hep, japan, pharmaceuticals, received

MOCHIDA'S IFN-BETA APPROVED FOR HEP C

Article | 28 February 1994

In Japan, Mochida Pharmaceuticals has received approval to market its interferon beta product, IFN-beta Mochida, for the treatment of hepatitis ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Schering Plough

Schering-Plough

Go to company listing

Related Drugs

Alpha

Prolastin

Interferon alfa-2b, Recombinant for Injection

Intron A

Go to drug listing